Oct 30, 2020 / 12:30PM GMT
Operator
It is now my pleasure to turn today's program over to Mr. Patrick O'Brien, Senior Vice President, Investor Relations. Sir, the floor is yours.
Patrick O'Brien - Ligand Pharmaceuticals Incorporated - SVP of IR
Thank you, and welcome to Ligand's Third Quarter 2020 Financial Results and Business Update Conference Call.
Consistent with the recommendations for social distancing, all of our speakers for this call are in separate locations. Speaking today for Ligand will be John Higgins, CEO; Matt Foehr, COO; and Matt Korenberg, CFO.
We will be using slides together with our discussion today. We will also use non-GAAP financial measures and some of our statements will be forward-looking. Additional information concerning risk factors and other matters concerning Ligand can be found in the Ligand's earnings release issued earlier this morning and the slides associated with this call and periodic filings with the SEC.
As a reminder, Ligand takes no obligation to revise or update any statements to reflect events or
Q3 2020 Ligand Pharmaceuticals Inc Earnings Call Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers